KW-2449
CAS No. 1000669-72-6
KW-2449 ( KW 2449;KW2449 )
Catalog No. M10007 CAS No. 1000669-72-6
A multikinase inhibitor of FLT3/ABL/ABL-T315I/Aurora A/Aurora B with IC50 of 6.6/14/4/48/48 nM respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 30 | In Stock |
|
5MG | 47 | In Stock |
|
10MG | 65 | In Stock |
|
25MG | 133 | In Stock |
|
50MG | 246 | In Stock |
|
100MG | 457 | In Stock |
|
500MG | 1017 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKW-2449
-
NoteResearch use only, not for human use.
-
Brief DescriptionA multikinase inhibitor of FLT3/ABL/ABL-T315I/Aurora A/Aurora B with IC50 of 6.6/14/4/48/48 nM respectively.
-
DescriptionA multikinase inhibitor of FLT3/ABL/ABL-T315I/Aurora A/Aurora B with IC50 of 6.6/14/4/48/48 nM respectively; has little effect on PDGFRβ, IGF-1R, EGFR, and various serine/threonine kinases at 1 uM; exhibits potent growth inhibitory effects on leukemia cells with FLT3 mutations, resulting in the down-regulation of phosphorylated-FLT3/STAT5, G1 arrest, and apoptosis; orally active.Blood Cancer Discontinued
-
SynonymsKW 2449;KW2449
-
PathwayTyrosine Kinase
-
TargetFLT3
-
RecptorAbl;Abl(T315I);AuroraA;FGFR1;FLT3;FLT3(D835Y);JAK2;Kit;Src
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number1000669-72-6
-
Formula Weight332.40
-
Molecular FormulaC20H20N4O
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(C1=CC=C(/C=C/C2=NNC3=C2C=CC=C3)C=C1)N4CCNCC4
-
Chemical NameMethanone, [4-[2-(1H-indazol-3-yl)ethenyl]phenyl]-1-piperazinyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Shiotsu Y, et al. Blood. 2009 Aug 20;114(8):1607-17.
2. Nguyen T, et al. Clin Cancer Res. 2011 May 15;17(10):3219-32.
3. Pratz KW, et al. Blood. 2009 Apr 23;113(17):3938-46.
2. Nguyen T, et al. Clin Cancer Res. 2011 May 15;17(10):3219-32.
3. Pratz KW, et al. Blood. 2009 Apr 23;113(17):3938-46.
molnova catalog
related products
-
Quizartinib hydrochl...
Quizartinib (AC220) is a potent, selective, second-generation FLT3 inhibitor with Kd of 1.6 nM.
-
Crenolanib
Crenolanib (CP-868596) is a potent, selective PDGFR/Flt-3 inhibitor.
-
KIN1148
KIN1148 is a novel small-molecule adjuvant that acts through the RIG-I pathway and IRF-3 transcription factor to stimulate inN/Ate immunity and protection following viral infection.